Skip to main content

Advertisement

Log in

Negative affect in systemic sclerosis

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Negative affect appears frequently in rheumatic diseases, but studies about their importance and prevalence in systemic sclerosis patients are scarce, and the results are inconclusive separately. We conducted a comprehensive search on April 2013 of PubMed, Medline, and PsycINFO databases to identify original research studies published. A total of 48 studies were included in this systematic review. We found negative emotions have very high levels in these patients, compared to both healthy population other chronic rheumatic patients assessed with the same instruments and cutoffs. Depression has been, of the three negative emotions that we approach to in this review, the most widely studied in systemic sclerosis, followed by anxiety. Despite the fact that anger is a common emotion in these diseases is poorly studied. Methodologic issues limited the ability to draw strong conclusions from studies of predictors. Disease-specific symptoms (swollen joints, gastrointestinal and respiratory symptoms and digital ulcers) and factors related to physical appearance were associated with negative emotions. Interdisciplinary care and biopsychosocial approach would have a great benefit in the clinical management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc 273:59–65

    Article  CAS  Google Scholar 

  2. Consedine NS, Magai C, Cohen CI, Gilespie M (2002) Ethnic variation in the impact of negative affect and emotion inhibition on the health of older adults. J Gerontol Ser B Psychol Sci 57B:396–408

    Article  Google Scholar 

  3. Schulz R, Drayer RA, Rollman BL (2002) Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry 52:205–225

    Article  PubMed  Google Scholar 

  4. Suls J, Bunde J (2005) Anger, anxiety and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 131:260–300

    Article  PubMed  Google Scholar 

  5. Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019

    PubMed  Google Scholar 

  6. Cuijpers P, Smit H (2002) Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 72:227–236

    Article  PubMed  Google Scholar 

  7. Rosemann T, Laux G, Kuehlein T (2007) Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany. BMC Musculoskelet Disord 8:79

    Article  PubMed Central  PubMed  Google Scholar 

  8. Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752

    Article  PubMed  Google Scholar 

  9. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  10. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M, Canadian Scleroderma Research Group (2008) High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 59(3):431–437

    Article  PubMed  Google Scholar 

  12. Thombs BD, Hudson M, Schieir O, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum 59(3):438–443

    Article  PubMed  Google Scholar 

  13. Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD, Canadian Scleroderma Research Group (2013) Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One 8(1):e53923. doi:10.1371/journal.pone.0053923

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61(7):966–973. doi:10.1002/art.24614

    Article  PubMed  Google Scholar 

  15. Milette K, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2010) Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) 49(4):789–796

    Article  Google Scholar 

  16. Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, (CSRG) Canadian Scleroderma Research Group (2012) Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One 7(12):e52028. doi:10.1371/journal.pone.0052028

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  PubMed  CAS  Google Scholar 

  18. Beck A (1972) Screening depressed patients in family practice: a rapid technique. Postgrad Med 56:81–85

    Google Scholar 

  19. Montgomery SA, Asberg M (1979) A new scale designed to be sensitive to change. Br J Psychiatry 134:382–389

    Article  PubMed  CAS  Google Scholar 

  20. Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70

    Article  PubMed  CAS  Google Scholar 

  21. Bedford A, Fould GA (1978) Delusions-symptoms-states Inventory States of Anxiety and Depression (Manual). NFER Publishing, Windsor

    Google Scholar 

  22. Derogatis LR, Covi L, Lipman RS (1973) The SCL-90: an out-patients psychiatric rating scale. Psychopharmacol Bull 9:13–28

    PubMed  CAS  Google Scholar 

  23. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 17:1–16

    Article  Google Scholar 

  24. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35:1–10

    Article  PubMed  CAS  Google Scholar 

  25. Derogatis LR (1986) The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res 30:77–91

    Article  PubMed  CAS  Google Scholar 

  26. Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M, Canadian Scleroderma Research Group Investigators (2008) Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59(2):279–284. doi:10.1002/art.23344

    Article  PubMed  Google Scholar 

  27. Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (CSRG) (2012) Influence of somatic symptoms on PHQ-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res (Hoboken). doi:10.1002/acr.21675

    Google Scholar 

  28. Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 29(6):1035–1040

    Google Scholar 

  29. Benrud-Larson LM, Haythornwaite JA, Heinberg LJ, Boling C, Reed J, White B, Wigley FM (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275

    Article  PubMed  Google Scholar 

  30. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, Togashi R, Tada Y, Suzuki N, Nagasawa K (2003) Frecuency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30(8):1782–1787

    PubMed  Google Scholar 

  31. Richards HL, Herrick AL, Griffin K, Gwilliam PDH, Loukes J, Fortune DG (2003) Systemic sclerosis: patient’s perceptions of their condition. Arthritis Care Res 49(5):689–696

    Article  Google Scholar 

  32. Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornwaite JA (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22(2):130–139

    Article  PubMed  Google Scholar 

  33. Vera-Lastra O, Martinez R, Pacheco M, Medina G, Jara LJ, Ariza R (2006) Frecuency of depressive symptoms in systemic sclerosis (SSC) and treatment with flouxetine. J Clin Rheumatol 12(4 Suppl):S83

    Article  Google Scholar 

  34. Thombs BD, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59(4):504–509. doi:10.1002/art.23524

    Article  PubMed  Google Scholar 

  35. Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72:408–411

    Article  PubMed  Google Scholar 

  36. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM (2005) Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 32(1):51–57

    PubMed  Google Scholar 

  37. Taillefer SS, Baron M, Hudson M (2005) Predictors of depressive symptoms in patients with systemic sclerosis (SSC). Ann Rheum Dis 64:925

    Google Scholar 

  38. Taillefer S, Baron M, Hudson M (2005) Disability, pain and dyspnea predict levels of depression in systemic sclerosis (SSC). Arthritis Rheum 52(9 S):1569

    Google Scholar 

  39. Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, Tsevat J (2007) Health values of patients with systemic sclerosis. Arthritis Rheum 57(1):86–93

    Article  PubMed  Google Scholar 

  40. Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, Mayes MD, Clements PJ, Khanna D (2011) Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology 50:330–334

    Article  PubMed Central  PubMed  Google Scholar 

  41. Ostojic P, Zivojinovic S, Reza T, Damjanov N (2010) Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Mod Rheumatol 20(4):353–357

    Article  PubMed  Google Scholar 

  42. Mozzetta A, Antinone V, Alfani S, Neri P, Bonda PGF, Pasquini P, Puddu P, Picardi A (2008) Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 22(3):336–340

    Article  PubMed  CAS  Google Scholar 

  43. Baubet T, Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, Moroni C, Belin C, Pagnoux C, Moro MR, Guillevin L, Mouthon L (2011) Mood and anxiety disorders in systemic sclerosis patients. Presse Med 40(2):e111–e119

    Article  PubMed  Google Scholar 

  44. Angelopoulos NV, Drosos AA, Moutsopoulos HM (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70:145–150

    Article  PubMed  CAS  Google Scholar 

  45. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2013) Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) 52(4):669–675. doi:10.1093/rheumatology/kes347

    Article  Google Scholar 

  46. Wafki F, Amine B, Ibn Yacoub Y, Laatiriss A, Znat F, Abouqal R, Hajjaj-Hassouni N (2012) Depression among the Moroccan systemic sclerosis. Clin Rheumatol 31(1):73–77

    Article  PubMed  Google Scholar 

  47. Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M, Canadian Scleroderma Research Group, Hudson M (2010) The association between disease activity and duration in systemic sclerosis. J Rheumatol 37(11):2299–2306

    Article  PubMed  Google Scholar 

  48. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, For the Scleroderma Cinical Trials Consortium (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46(9):2410–2420

    Article  PubMed  Google Scholar 

  49. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Silver RM (2004) How do functional status and gastrointestinal dysfunction influence depression among patients with systemic sclerosis? Arthritis Rheum 50(9):S1174

    Google Scholar 

  50. Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V (2007) Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psycosom Res 62(1):47–56

    Article  Google Scholar 

  51. Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50(7):1280–1287

    Article  Google Scholar 

  52. Sariyildiz MA, Batmaz I, Budulgan M, Bozkurt M, Yazmalar L, Inanir A, Celepkolu T, Cevik R (2013) Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int (Epub ahead of print)

  53. Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornwaite JA (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22(2):130–139

    Article  PubMed  Google Scholar 

  54. Lawrence JW, Heinberg LJ, Roca R, Munster A, Spence R, Fauerbach JA (1998) Development and validation of the Satisfaction with Appearance Scale: assessing body image among burn-injured patients. Psychol Assess 10:64–70

    Article  Google Scholar 

  55. Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH (2012) Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res 72(3):199–204. doi:10.1016/j.jpsychores.2011.12.005

    Article  PubMed  Google Scholar 

  56. Malcarne VL, Hansdottir I, Greenbergs HL, Clements PJ, Weisman MH (1999) Appearance self-esteem in systemic sclerosis. Cogn Ther Res 23(2):197–208

    Article  Google Scholar 

  57. Antonowsky A (1993) The structure and properties of the sense of coherence scale. Soc Sci Med 36:725–733

    Article  Google Scholar 

  58. Buck U, Poole J, Mendelson C (2010) Factors related to self-efficacy in persons with scleroderma. Musculoskelet Care 8(4):197–203. doi:10.1002/msc.181

    Article  Google Scholar 

  59. McFarlane AC, Brooks PM (1988) Determinants of disability in rheumatoid arthritis. Br J Rheumatol 27:7–14

    Article  PubMed  CAS  Google Scholar 

  60. Katz PP, Yelin EH (1993) Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 20:790–796

    PubMed  CAS  Google Scholar 

  61. Wright GE, Parker JC, Smarr KL, Schoenfeld-Smith K, Buckelew SP, Slaughter JR, Johnson JC, Hewett JE (1996) Risk factors for depression in rheumatoid arthritis. Arthritis Care Res 9:264–272

    Article  PubMed  CAS  Google Scholar 

  62. Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, Franceschini F, Cattaneo R (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24(1):48–54

    Article  PubMed  Google Scholar 

  63. Müller H, Rehberger P, Günther C, Schmitt J (2012) Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol 166(2):343–353

    Article  PubMed  Google Scholar 

  64. Medsger TA (2003) Natural history of systemic sclerosis and the assesment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29:255–273

    Article  PubMed  Google Scholar 

  65. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Silver RM (2004) How do functional status and gastrointestinal dysfunction influence depression among patients with systemic sclerosis? Arthritis Rheum 50(9):S1174

    Google Scholar 

  66. Hamilton M (1969) Diagnosis and rating of anxiety. Br J Psychiatry 3:76–79 (Special publication)

    Google Scholar 

  67. Zung WWK (1971) A rating instrument for anxiety disorders. Psychosomatics 12:371–379

    Article  PubMed  CAS  Google Scholar 

  68. Nguyen C, Bérezné A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A, Morell-Dubois S, Revel M, Guillevin L, Poiraudeau S, Mouthon L, Groupe Français de Recherche sur la Sclérodermie (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6(3):e17551

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  69. Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, Nguyen C, Hachulla E, Guillevin L, Poiraudeau S, Mouthon L (2011) Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 63(2):277–285. doi:10.1002/acr.20342

    Article  Google Scholar 

  70. van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH (2007) Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford) 46(5):872–876

    Article  Google Scholar 

  71. Caine TM, Foulds GA, Hope K (1967) Manual of the Hostility and Direction of Hostility Questionnaire. University of London Press, London

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leticia Leon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leon, L., Abasolo, L., Redondo, M. et al. Negative affect in systemic sclerosis. Rheumatol Int 34, 597–604 (2014). https://doi.org/10.1007/s00296-013-2852-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2852-7

Keywords

Navigation